CIK 0001841330
- Emerging growth company
Pasithea Therapeutics Corp.
Sign in to watch- Ticker
- KTTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851591963
- Phone
- +1 702-514-4174
- Business address
- 1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH, FL, 33139
- 4 Open-market buy Director bought 30,000 shares at $0.43 ($12,930)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 9,206 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Executive Officer acquired 5,000 shares (grant or award)
- 4 Open-market buy Member of 10% owner group bought 1,000 shares at $1.11 ($1,110)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Member of 10% owner group bought 64,357 shares at an average $1.19 ($76,299)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Member of 10% owner group bought 88,901 shares at an average $1.13 ($100,367)
- 4 Open-market buy Member of 10% owner group bought 22,828 shares at an average $1.15 ($26,293)
- 4 Open-market buy Member of 10% owner group bought 54,644 shares at $1.30 ($70,939)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Member of 10% owner group bought 155,773 shares at $1.21 ($188,283)
- 3 Insider Initial Statement of Ownership
Page 3 of 5 · 81 filings